Frazier Financial Advisors »

Aurinia Pharmaceuticals shares owned by Frazier Financial Advisors

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Frazier Financial Advisors from 13F filings

Historical chart of Frazier Financial Advisors investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Frazier Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Frazier Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $26k 3.5k 7.33
2024-06-30 $29k 5.1k 5.71
2024-03-31 $2.5k 500 5.01
2023-12-31 $4.5k 500 8.99

More positions owned by Frazier Financial Advisors

Vanguard Specialized Funds Div App Etf (VIG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Wisdomtree Tr Currncy Int Eq (DDWM)
Wisdomtree Tr Us Midcap Divid (DON)
Accenture Plc Ireland Shs Class A (ACN)
Vanguard Index Fds Small Cp Etf (VB)
Wisdomtree Tr Us Smallcap Divd (DES)
Abbvie (ABBV)
Apple (AAPL)
Abbott Laboratories (ABT)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Aces Ultra Shr (GSST)
JPMorgan Chase & Co. (JPM)
Bath &#38 Body Works In (BBWI)

View all positions for Frazier Financial Advisors

Top funds holding Aurinia Pharmaceuticals

Armistice Capital
BlackRock
BlackRock
Tang Capital Management
NEA Management Company
State Street Corporation
Goldman Sachs Group
Nuveen Asset Management
Geode Capital Management
Vanguard Group
Rock Springs Capital Management
Susquehanna International
Citadel Advisors
Schroder Investment Management Group
Northern Trust

View all funds holding Aurinia Pharmaceuticals